Engineering Microencapsulated Probiotics for Enhanced Aflatoxin M1 Mitigation in Milk

Abstract Aflatoxin M 1 is a major mycotoxin found primarily in milk and dairy products that causes a severe public health risk to dairy product safety and the dairy industry. Therefore, the present study explored the effectiveness of micro-encapsulated Lactobacillus acidophilus , Lactobacillus Casei and Bifidobacterium bifidum in reducing AFM 1 in milk as promising and emerging strategies for eliminating and controlling AFM1 in milk. Nonetheless, it is challenging to maintain a high number of live cells in probiotic foods during storage and gastrointestinal transit. Microencapsulation of probiotic bacteria is an efficient approach to increase probiotic viability by minimizing cell exposure to harsh environments via the gastrointestinal tract before releasing them into the colon. Hence, Lactobacillus Casei , Lactobacillus acidophilus and Bifidobacterium bifidum were encapsulated with ionic gelation techniques in alginate/inulin microcapsules (LC/AL/IN), (LA/AL/IN), and (BB/AL/IN), with encapsulation yields of 87.5 ± 0.50%, 90.3 ± 0.71%, and 83.2 ± 0.33%, respectively. The morphology of the microcapsules was investigated with a scanning electron microscope. The encapsulation yield, particle size, zeta potential, and FTIR were investigated for the prepared microcapsule. The effect of (LC/AL/IN), (LA/AL/IN), and BB/AL/IN alone and their combined mixture was tested for mitigation of aflatoxin M1 in artificially contaminated milk with a reduction percentage of 91%, 91%, 76%, and 95.66%, respectively. These findings suggested that microencapsulated probiotics represent a safe and effective strategy for AFM1 management with a strong ability to decrease AFM1 in milk.

Authors

Institutions

Publication Details

Journal
Probiotics and Antimicrobial Proteins
Published
2026-11-16
DOI
https://doi.org/10.1007/s12602-026-11248-8
Primary Topic
Mycotoxins in Agriculture and Food
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Engineering Microencapsulated Probiotics for Enhanced Aflatoxin M1 Mitigation in Milk

Shaimaa A. Khalid, Amira A. Elokle, Marwa E. A. Kholeaf, Ahmed S. Abo Dena et al.
2 links
Probiotics and Antimicrobial Proteins
Mycotoxins in Agriculture and Food
article

Engineering Microencapsulated Probiotics for Enhanced Aflatoxin M1 Mitigation in Milk

Shaimaa A. Khalid, Amira A. Elokle, Marwa E. A. Kholeaf, Ahmed S. Abo Dena, Asmaa E. Hassan
article en

Abstract

Abstract Aflatoxin M 1 is a major mycotoxin found primarily in milk and dairy products that causes a severe public health risk to dairy product safety and the dairy industry. Therefore, the present study explored the effectiveness of micro-encapsulated Lactobacillus acidophilus , Lactobacillus Casei and Bifidobacterium bifidum in reducing AFM 1 in milk as promising and emerging strategies for eliminating and controlling AFM1 in milk. Nonetheless, it is challenging to maintain a high number of live cells in probiotic foods during storage and gastrointestinal transit. Microencapsulation of probiotic bacteria is an efficient approach to increase probiotic viability by minimizing cell exposure to harsh environments via the gastrointestinal tract before releasing them into the colon. Hence, Lactobacillus Casei , Lactobacillus acidophilus and Bifidobacterium bifidum were encapsulated with ionic gelation techniques in alginate/inulin microcapsules (LC/AL/IN), (LA/AL/IN), and (BB/AL/IN), with encapsulation yields of 87.5 ± 0.50%, 90.3 ± 0.71%, and 83.2 ± 0.33%, respectively. The morphology of the microcapsules was investigated with a scanning electron microscope. The encapsulation yield, particle size, zeta potential, and FTIR were investigated for the prepared microcapsule. The effect of (LC/AL/IN), (LA/AL/IN), and BB/AL/IN alone and their combined mixture was tested for mitigation of aflatoxin M1 in artificially contaminated milk with a reduction percentage of 91%, 91%, 76%, and 95.66%, respectively. These findings suggested that microencapsulated probiotics represent a safe and effective strategy for AFM1 management with a strong ability to decrease AFM1 in milk.

Probiotics and Antimicrobial Proteins
Academy of Scientific Research and Technology (EG), National Organization for Drug Control and Research (EG), Zewail City of Science and Technology (EG), Animal Health Research Institute (TW), Agricultural Research Center (EG), Egyptian Drug Authority (EG)
Science and Technology Development Fund
Good health and well-being, Zero hunger
Mycotoxins in Agriculture and Food
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon